Jurox USA
Jurox USA began operations from its Kansas City, MO headquarters in 2014 and serves as the sales and marketing resource for Jurox Pty Ltd products once they are introduced into the United States. The products are available from the entirety of the domestic animal health distribution network. Since the U.S. launch of Alfaxan, nearly 5000 specialty and full service veterinary hospitals have incorporated the product into their anesthetic protocols. Every day, around the globe, Alfaxan injectable anesthetic is used in thousands of anesthesia procedures. Its effectiveness, its wider safety profile and its versatility are raising the bar for injectable agents used in induction and total injectable anesthetic procedures. And now, Jurox introduces new Alfaxan Multidose, an injectable anesthetic with the same superior pharmacodynamic and pharmacokinetic characteristics as original Alfaxan, but in a preserved formulation that is FDA-approved for 56 days on the shelf, post-broaching.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Animal Heath
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About us
The recent introduction of Alfaxan Multidose with its FDA-registered 56 day shelf life, post broaching, will provide even more flexibility for the surgeons who use it. Click here for more information about Alfaxan Multidose injectable anesthetic.
Jurox USA currently fields 18 sales representatives and managers, four Inside Sales Representatives and four Technical Services Veterinarians. Check the job link in “Contact Us” as our team is growing to service increasing demand.